ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 81 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,438,000 | -57.6% | 250,000 | 0.0% | 1.31% | -35.1% |
| Q3 2018 | $3,390,000 | +14.3% | 250,000 | 0.0% | 2.02% | +18.9% |
| Q2 2018 | $2,965,000 | +5.7% | 250,000 | 0.0% | 1.69% | -2.9% |
| Q1 2018 | $2,805,000 | +68.0% | 250,000 | 0.0% | 1.74% | +44.1% |
| Q4 2017 | $1,670,000 | -18.3% | 250,000 | 0.0% | 1.21% | -14.5% |
| Q3 2017 | $2,045,000 | +81.8% | 250,000 | 0.0% | 1.42% | +58.2% |
| Q2 2017 | $1,125,000 | -18.2% | 250,000 | 0.0% | 0.90% | -12.6% |
| Q1 2017 | $1,375,000 | +37.1% | 250,000 | 0.0% | 1.02% | +22.2% |
| Q4 2016 | $1,003,000 | -43.1% | 250,000 | 0.0% | 0.84% | -50.4% |
| Q3 2016 | $1,763,000 | -13.3% | 250,000 | 0.0% | 1.69% | -20.6% |
| Q2 2016 | $2,033,000 | +0.2% | 250,000 | 0.0% | 2.13% | +13.0% |
| Q1 2016 | $2,028,000 | -32.7% | 250,000 | 0.0% | 1.88% | +3.6% |
| Q4 2015 | $3,013,000 | – | 250,000 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 12,025,999 | $66,263,000 | 2.30% |
| Abingworth LLP | 250,000 | $1,375,000 | 1.02% |
| Tekla Capital Management LLC | 1,466,368 | $8,080,000 | 0.31% |
| Rock Springs Capital Management LP | 875,000 | $4,821,000 | 0.28% |
| QVT Financial LP | 1,360,647 | $6,940,000 | 0.22% |
| Vident Investment Advisory, LLC | 232,641 | $1,282,000 | 0.13% |
| Hillhouse Capital Management | 1,190,476 | $6,560,000 | 0.13% |
| Orbimed Advisors | 1,914,660 | $10,550,000 | 0.12% |
| Granite Investment Partners, LLC | 195,571 | $1,078,000 | 0.07% |
| Monashee Investment Management LLC | 25,000 | $138,000 | 0.06% |